Citation Information :
Vivas-Giraldo JP, Bravo-Acosta JD. Characterization of diabetic retinopathy in a screening program in Medellin, Colombia, in 2018. 2021; 95 (3E):112-117.
Purpose: To identify the prevalence of diabetic retinopathy in diabetic patients of a screening program of the Hospital San Vicente Fundación in Medellin (Colombia), to describe the sociodemographic characteristics and the type of diabetic retinopathy and to evaluate the percentage of patients with vision-threatening diabetic retinopathy.
Method: This is a cross-sectional descriptive study, in which diabetic patients of all ages and both genders were evaluated in the “No more blind from diabetes” campaign of the Hospital San Vicente Fundación in Medellín, conducted in the year 2018.
Results: We evaluated 610 diabetic patients from the 2018 campaign. Most of the patients had type 2 diabetes, in total 528 (74.8%). Of the patients evaluated, retinopathy was found in 115 cases, for a prevalence of 18.8%. Proliferative retinopathy was found in 17 (14.7%) patients, and non-proliferative retinopathy was the most frequent in 98 patients (85.2%). The subgroup of vision-threatening diabetic retinopathy was made up of 48 (7.8%) patients, of which the diagnosis had not been made previously in 7 (14.5%) cases.
Conclusions: The prevalence of diabetic retinopathy in the population studied is comparable with some of the studies carried out in some Latin American countries. This work provides relevant local epidemiological data about diabetic retinopathy and reinforces the importance of continuing screening campaigns to prevent cases of blindness with early diagnosis and treatment.
Preferred Practice Pattern® Guidelines. Diabetic retinopathy. American Academy of Ophthalmology Retina/Vitreous Panel. 2017. Disponible en: www.aao.org/ppp
Wu L, Fernández-loaiza P, Sauma J, Hernandez-Bogantes E, Masis M, Fernandez-Loaiza P, et al. Classification of diabetic retinopathy and diabetic macular edema. World J Diabetes. 2013;4:290-4.
Guías clínicas para el manejo de la patología ocular del diabético. Consejo Internacional de Oftalmología. 2017. Disponible en: http://www.icoph. org/
Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye. 2004;18:963-83.
Huang OS, Tay WT, Ong PG, Sabanayagam C, Cheng C, Tan GS, et al. Prevalence and determinants of undiagnosed diabetic retinopathy and vision-threatening retinopathy in a multiethnic Asian cohort: the Singapore Epidemiology of Eye Diseases (SEED) study. Br J Ophthalmol Publ. 2015;99:1614-21.
Amador-Rosa ME, García JA, Amador-Rosa ME. Prevalencia de retinopatía diabética en el Instituto Nacional del Diabético de Honduras, en el periodo febrero-julio 2016. Arch Med. 2016;12:1-7.
Zhang K, Ferreyra HA, Grob S. Diabetic retinopathy: genetics and etiologic mechanisms. En: Ryan SJ, editor. Retina, 5th ed. Philadelphia: Elsevier Saunders; 2013. p. 925-39.
Vallejo EV, Rodríguez FJ. Epidemiología de la retinopatía diabética y su relación con la diabetes. Rev Colomb Endocrinol Diabetes Metab. 2016;3:12-5.
Yau JWY, Rogers SL, Kawasaki R. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556-64.
Análisis de situación de salud visual en Colombia. Ministerio de Salud de Colombia. 2016. Disponible en: https://www.minsalud.gov.co
Abuauad S, Guzmán P, Urzúa C. Prevalencia de retinopatía diabética y edema macular en población diabética del CESFAM Cordillera Andina de Los Andes. Rev Chil Salud Publica. 2014;18:81-6.
Prado-Serrano A, Guido-Jiménez DMA, Camas-Benítez DJT. Prevalencia de retinopatía diabética en población mexicana. Rev Mex Oftalmol. 2009;83:261-6.
Chibás AR, Lozada IR. Caracterización de retinopatía diabética en pacientes del Policlínico Universitario “Asdrúbal López”. Rev Inf Cient. 2009;61:1-11.
World Health Organization. Prevention of blindness from diabetes mellitus: report of a WHO consultation. Geneva: WHO; 2006.
Varma R, Bressler NM, Doan Q V, Gleeson M, Danese M, Bower JK, et al. Prevalence of and risk factors for diabetic macular edema in the United States. JAMA Ophthalmol. 2014;132:1334-40.
Yáñez B, Murillo JP, Arbañil H. Diabetic retinopathy: prevalence and associated risk factors. Revista Médica Carrionica. 2016;3:3-14.
Acan D, Calan M, Er D, Arkan T, Kocak N, Bayraktar F, et al. The prevalence and systemic risk factors of diabetic macular edema: a cross-sectional study from Turkey. BMC Ophthalmol. 2018;18:1-8.
Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis. 2015;2:1-25.
Soto A, Cruz C. Retinopatía diabética y edema macular diabético: prevalencia en una población de atención primaria de Antofagasta. Rev Chil Salud Pública. 2018;22:155-60.
Gustafsson S, Hellgren K-J. Sight-threatening diabetic retinopathy in a Swedish County. Orebro University; 2017. Disponible en: http://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-66795
Younis N, Broadbent DM, Vora JP, Harding SP. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet. 2003;361:195-200.